Bariatric surgery in the treatment of morbid obesity and chronic kidney disease

Introduction. Chronic kidney disease (CKD) is a serious disease, the most common causes of which are obesity, diabetes, metabolic disorders, cardiovascular disease, and others. Approximately 10 % of adults worldwide have chronic kidney disease, resulting in 1,2 million deaths each year. Epidemiological studies have determined the association of obesity with the development of end-stage chronic kidney disease and the risk of hemodialysis sessions. The purpose of the study. To evaluate the effectiveness of bariatric surgery in terms of reducing the risks of end-stage chronic kidney disease, as well as improving the quality of life in patients on hemodialysis who underwent surgery for obesity. Materials and methods. Literature reviews and articles describing the experience of bariatric surgery in patients with chronic kidney disease and patients on hemodialysis. Results. The effectiveness of bariatric interventions in the treatment of morbid obesity and metabolic syndrome has been undeniable and proven. The possibility of treating patients with progressive renal failure in patients with obesity through surgical methods is relevant and discussed. First of all, bariatric surgery. Conclusion. Bariatric surgery significantly improves the quality of life and reduces the risk of mortality in patients with chronic kidney disease of any stage.